138 related articles for article (PubMed ID: 38033933)
1. Evaluation of plasma fibrinogen degradation products, D-dimer, and mast cells in oral submucous fibrosis.
Sharma I; Wanjari S; Parwani R; Tekade S; Azad A; Azad A
J Oral Maxillofac Pathol; 2023; 27(3):438-442. PubMed ID: 38033933
[TBL] [Abstract][Full Text] [Related]
2. Estimation of plasma fibrinogen degradation products in oral submucous fibrosis: A clinico-pathological study.
Reshma VJ; Anwar AS; Mufeed A; Roshni A
J Int Soc Prev Community Dent; 2015; 5(4):309-13. PubMed ID: 26312231
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Plasma Fibrinogen Degradation Products in Areca Nut Chewers with and without Oral Submucous Fibrosis.
Gupta S; Sm M; Jawanda MK; Bharti A
J Clin Diagn Res; 2014 Nov; 8(11):ZC27-30. PubMed ID: 25584311
[TBL] [Abstract][Full Text] [Related]
4. A study on mast cell number and lipid profile in oral submucous fibrosis.
Husain B; Shreedhar B; Kamboj M; Natarajan S
Oral Health Dent Manag; 2014 Jun; 13(2):412-7. PubMed ID: 24984657
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibrinogen degradation products in oral submucous fibrosis.
Gupta S; Jawanda MK; Mehta N; Arora V; Yadav V
J Int Soc Prev Community Dent; 2015; 5(3):141-6. PubMed ID: 26236671
[TBL] [Abstract][Full Text] [Related]
6. Estimation of copper in saliva and areca nut products and its correlation with histological grades of oral submucous fibrosis.
Mohammed F; Manohar V; Jose M; Thapasum AF; Mohamed S; Shamaz BH; D'Souza N
J Oral Pathol Med; 2015 Mar; 44(3):208-13. PubMed ID: 25047540
[TBL] [Abstract][Full Text] [Related]
7. Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review.
Gupta S; Sandhu H; Nadar KT; Ocampo Escobedo RL; Gupta R; Subbappa A; Bhullar HS; Kaur M
J Int Soc Prev Community Dent; 2023; 13(2):89-95. PubMed ID: 37223447
[TBL] [Abstract][Full Text] [Related]
8. Identification of the pattern of copper as an etiological factor in oral submucous fibrosis: a cytological study.
Sharma A; Sahni P; Nayak MT; Singhvi A; Kumar R
J Exp Ther Oncol; 2014; 10(4):317-23. PubMed ID: 25509987
[TBL] [Abstract][Full Text] [Related]
9. Roles of CYP1A1 and CYP2E1 Gene Polymorphisms in Oral Submucous Fibrosis.
Yaming P; Urs AB; Saxena A; Zuberi M
Asian Pac J Cancer Prev; 2016; 17(7):3335-40. PubMed ID: 27509973
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic interventions in oral submucous fibrosis: an experimental and clinical study.
Singh V; Mohammad S; Pant AP; Saimbi CS; Srivastava R
J Maxillofac Oral Surg; 2015 Jun; 14(2):278-90. PubMed ID: 26028848
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Copper Levels in Dental Calculus of OSF Patients with Chewing Dried Areca-Nut Quids in Hunan Province of Mainland China.
He XF; Wang H; Tian Y; Zhang T; Qiu ZP; Cui XJ; Zhou JS; Yan XL; Wu YW; Pan YS; Ning YB; Chen L; Zhang KL; Zhao WH; Sharma D; Tan XD; Zhang MB
Biol Trace Elem Res; 2023 Feb; 201(2):677-682. PubMed ID: 35332437
[TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis of oral submucous fibrosis by chewing the areca nut.
Wang L; Tang Z
J Leukoc Biol; 2022 Feb; 111(2):469-476. PubMed ID: 34124802
[TBL] [Abstract][Full Text] [Related]
13. Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis.
Pant I; Kumar N; Khan I; Rao SG; Kondaiah P
PLoS One; 2015; 10(6):e0129252. PubMed ID: 26107172
[TBL] [Abstract][Full Text] [Related]
14. Role of chewing and smoking habits in the etiology of oral submucous fibrosis (OSF): a case-control study.
Shah N; Sharma PP
J Oral Pathol Med; 1998 Nov; 27(10):475-9. PubMed ID: 9831959
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunan Province, China.
Tang JG; Jian XF; Gao ML; Ling TY; Zhang KH
Community Dent Oral Epidemiol; 1997 Apr; 25(2):177-80. PubMed ID: 9181294
[TBL] [Abstract][Full Text] [Related]
16. The master switch: Comparative study of mast cell in oral epithelial dysplasia, oral submucous fibrosis and oral squamous cells carcinoma and their association with inflammation and angiogenesis.
Telagi N; Ahmed Mujib BR; Kulkarni PG; Naik R
J Oral Maxillofac Pathol; 2015; 19(1):25-9. PubMed ID: 26097302
[TBL] [Abstract][Full Text] [Related]
17. Expression of Salivary S100A7 Levels in Stage I Oral Submucous Fibrosis: A Clinical and Laboratory Study.
Raffat MA; Hadi NI; Alghamdi O; Al-Aali KA; Al Deeb M; Abduljabbar T; Vohra F
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1115-1119. PubMed ID: 32334479
[TBL] [Abstract][Full Text] [Related]
18. Oral submucous fibrosis: a case-control study in Chennai, South India.
Ranganathan K; Devi MU; Joshua E; Kirankumar K; Saraswathi TR
J Oral Pathol Med; 2004 May; 33(5):274-7. PubMed ID: 15078487
[TBL] [Abstract][Full Text] [Related]
19. Oral submucous fibrosis: a clinico-histopathological study in Chennai.
Kiran Kumar K; Saraswathi TR; Ranganathan K; Uma Devi M; Elizabeth J
Indian J Dent Res; 2007; 18(3):106-11. PubMed ID: 17687172
[TBL] [Abstract][Full Text] [Related]
20. Panax notoginseng saponins inhibit areca nut extract-induced oral submucous fibrosis in vitro.
Dai JP; Chen XX; Zhu DX; Wan QY; Chen C; Wang GF; Li WZ; Li KS
J Oral Pathol Med; 2014 Jul; 43(6):464-70. PubMed ID: 24484214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
